- 如果營收成長率小於推銷費用成長率, 可能代表產品需要很多的促銷才能賣掉, 或是產品有問題需要花額外的推銷成本來善後
- 發展品牌的公司不樂見推銷費用率的下滑, 對此類型公司推銷費用率等同於走技術類型公司的研發費用率
營收淨額 QoQ YoY | 推銷費用 QoQ YoY | 管理費用 QoQ YoY | 研發費 QoQ YoY | 推銷費用率(%) QoQ YoY | 管理費用率(%) QoQ YoY | 研發費用率(%) QoQ YoY | 員工人數 QoQ YoY | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
24Q2 (20) | 1.21 | -25.31 | 3933.33 | 0.18 | 260.0 | 0 | 0.07 | 40.0 | 16.67 | 0 | 0 | 0 | 14.88 | 381.98 | 0 | 5.79 | 87.44 | -97.11 | 0.00 | 0 | 0 | 111 | 0.0 | 0.0 |
24Q1 (19) | 1.62 | 121.92 | 3950.0 | 0.05 | 66.67 | 0 | 0.05 | 0 | -16.67 | 0 | 0 | 0 | 3.09 | -24.9 | 0 | 3.09 | 0 | -97.94 | 0.00 | 0 | 0 | 111 | 0.0 | 0.0 |
23Q4 (18) | 0.73 | 1360.0 | 508.33 | 0.03 | 50.0 | 200.0 | 0 | -100.0 | -100.0 | 0 | 0 | 0 | 4.11 | -89.73 | -50.68 | 0.00 | -100.0 | -100.0 | 0.00 | 0 | 0 | 111 | 0.0 | 0.0 |
23Q3 (17) | 0.05 | 66.67 | 66.67 | 0.02 | 0 | 0 | 0.06 | 0.0 | -14.29 | 0 | 0 | 0 | 40.00 | 0 | 0 | 120.00 | -40.0 | -48.57 | 0.00 | 0 | 0 | 111 | 0.0 | 0.0 |
23Q2 (16) | 0.03 | -25.0 | 50.0 | 0 | 0 | 0 | 0.06 | 0.0 | -25.0 | 0 | 0 | 0 | 0.00 | 0 | 0 | 200.00 | 33.33 | -50.0 | 0.00 | 0 | 0 | 111 | 0.0 | 0.0 |
23Q1 (15) | 0.04 | -66.67 | 300.0 | 0 | -100.0 | 0 | 0.06 | -14.29 | -14.29 | 0 | 0 | 0 | 0.00 | -100.0 | 0 | 150.00 | 157.14 | -78.57 | 0.00 | 0 | 0 | 111 | 0.0 | 0.0 |
22Q4 (14) | 0.12 | 300.0 | 500.0 | 0.01 | 0 | 0 | 0.07 | 0.0 | -22.22 | 0 | 0 | 0 | 8.33 | 0 | 0 | 58.33 | -75.0 | -87.04 | 0.00 | 0 | 0 | 111 | 0.0 | 0.0 |
22Q3 (13) | 0.03 | 50.0 | 200.0 | 0 | 0 | 0 | 0.07 | -12.5 | -12.5 | 0 | 0 | 0 | 0.00 | 0 | 0 | 233.33 | -41.67 | -70.83 | 0.00 | 0 | 0 | 111 | 0.0 | 0.0 |
22Q2 (12) | 0.02 | 100.0 | -50.0 | 0 | 0 | 0 | 0.08 | 14.29 | -11.11 | 0 | 0 | 0 | 0.00 | 0 | 0 | 400.00 | -42.86 | 77.78 | 0.00 | 0 | 0 | 111 | 0.0 | 0.0 |
22Q1 (11) | 0.01 | -50.0 | -85.71 | 0 | 0 | 0 | 0.07 | -22.22 | -12.5 | 0 | 0 | 0 | 0.00 | 0 | 0 | 700.00 | 55.56 | 512.5 | 0.00 | 0 | 0 | 111 | 0.0 | 0.0 |
21Q4 (10) | 0.02 | 100.0 | -50.0 | 0 | 0 | 0 | 0.09 | 12.5 | 0.0 | 0 | 0 | 0 | 0.00 | 0 | 0 | 450.00 | -43.75 | 100.0 | 0.00 | 0 | 0 | 111 | 0.0 | 0.0 |
21Q3 (9) | 0.01 | -75.0 | -75.0 | 0 | 0 | 0 | 0.08 | -11.11 | 0.0 | 0 | 0 | 0 | 0.00 | 0 | 0 | 800.00 | 255.56 | 300.0 | 0.00 | 0 | 0 | 111 | 0.0 | 0.0 |
21Q2 (8) | 0.04 | -42.86 | -42.86 | 0 | 0 | 0 | 0.09 | 12.5 | 0.0 | 0 | 0 | 0 | 0.00 | 0 | 0 | 225.00 | 96.88 | 75.0 | 0.00 | 0 | 0 | 111 | 0.0 | 0.0 |
21Q1 (7) | 0.07 | 75.0 | 75.0 | 0 | 0 | -100.0 | 0.08 | -11.11 | -27.27 | 0 | 0 | 0 | 0.00 | 0 | -100.0 | 114.29 | -49.21 | -58.44 | 0.00 | 0 | 0 | 111 | 0.0 | 0.0 |
20Q4 (6) | 0.04 | 0.0 | -63.64 | 0 | 0 | -100.0 | 0.09 | 12.5 | 12.5 | 0 | 0 | -100.0 | 0.00 | 0 | -100.0 | 225.00 | 12.5 | 209.38 | 0.00 | 0 | -100.0 | 111 | 0.0 | 0.0 |
20Q3 (5) | 0.04 | -42.86 | -60.0 | 0 | 0 | 0 | 0.08 | -11.11 | -20.0 | 0 | 0 | -100.0 | 0.00 | 0 | 0 | 200.00 | 55.56 | 100.0 | 0.00 | 0 | -100.0 | 111 | 0.0 | 0.0 |
20Q2 (4) | 0.07 | 75.0 | 0.0 | 0 | -100.0 | 0.0 | 0.09 | -18.18 | 0.0 | 0 | 0 | 0.0 | 0.00 | -100.0 | 0.0 | 128.57 | -53.25 | 0.0 | 0.00 | 0 | 0.0 | 111 | 0.0 | 0.0 |
20Q1 (3) | 0.04 | -63.64 | 0.0 | 0.01 | 0.0 | 0.0 | 0.11 | 37.5 | 0.0 | 0 | -100.0 | 0.0 | 25.00 | 175.0 | 0.0 | 275.00 | 278.12 | 0.0 | 0.00 | -100.0 | 0.0 | 111 | 0.0 | 0.0 |
19Q4 (2) | 0.11 | 10.0 | 0.0 | 0.01 | 0 | 0.0 | 0.08 | -20.0 | 0.0 | 0.01 | 0.0 | 0.0 | 9.09 | 0 | 0.0 | 72.73 | -27.27 | 0.0 | 9.09 | -9.09 | 0.0 | 111 | 0.0 | 0.0 |
19Q3 (1) | 0.1 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.01 | 0.0 | 0.0 | 0.00 | 0.0 | 0.0 | 100.00 | 0.0 | 0.0 | 10.00 | 0.0 | 0.0 | 111 | 0.0 | 0.0 |
營收淨額 YoY | 推銷費用 YoY | 管理費用 YoY | 研發費 YoY | 推銷費用率(%) YoY | 管理費用率(%) YoY | 研發費用率(%) YoY | 員工人數 YoY | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 (10) | 0.85 | 372.22 | 0.05 | 400.0 | 0.18 | -37.93 | 0 | 0 | 5.88 | 5.88 | 21.18 | -86.86 | 0.00 | 0 | 111 | 0.0 |
2022 (9) | 0.18 | 28.57 | 0.01 | 0 | 0.29 | -14.71 | 0 | 0 | 5.56 | 0 | 161.11 | -33.66 | 0.00 | 0 | 111 | 0.0 |
2021 (8) | 0.14 | -30.0 | 0 | 0 | 0.34 | -5.56 | 0 | 0 | 0.00 | 0 | 242.86 | 34.92 | 0.00 | 0 | 111 | 0.0 |
2020 (7) | 0.2 | -61.54 | 0.01 | -50.0 | 0.36 | -2.7 | 0.01 | -66.67 | 5.00 | 30.0 | 180.00 | 152.97 | 5.00 | -13.33 | 111 | 0.0 |
2019 (6) | 0.52 | -40.23 | 0.02 | 0.0 | 0.37 | -31.48 | 0.03 | -78.57 | 3.85 | 67.31 | 71.15 | 14.64 | 5.77 | -64.15 | 111 | 0.0 |
2018 (5) | 0.87 | -50.29 | 0.02 | -90.48 | 0.54 | 0.0 | 0.14 | -84.09 | 2.30 | -80.84 | 62.07 | 101.15 | 16.09 | -68.0 | 111 | 0.0 |
2017 (4) | 1.75 | 2.94 | 0.21 | 0.0 | 0.54 | 14.89 | 0.88 | -4.35 | 12.00 | -2.86 | 30.86 | 11.61 | 50.29 | -7.08 | 111 | 0.0 |
2016 (3) | 1.7 | 0.59 | 0.21 | 133.33 | 0.47 | 4.44 | 0.92 | 1.1 | 12.35 | 131.96 | 27.65 | 3.83 | 54.12 | 0.5 | 111 | -9.02 |
2015 (2) | 1.69 | -19.91 | 0.09 | -18.18 | 0.45 | -8.16 | 0.91 | -15.74 | 5.33 | 2.15 | 26.63 | 14.66 | 53.85 | 5.2 | 122 | 6.09 |
2014 (1) | 2.11 | 31.06 | 0.11 | -47.62 | 0.49 | -3.92 | 1.08 | 6.93 | 5.21 | 0 | 23.22 | 0 | 51.18 | 0 | 115 | 0.88 |